AGRAWAL SUNDEEP reported 1 transaction at BLOSSOMHILL THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/10/2026ACC: 0001840599-26-000003
Director
Since Aug 2026
+23.90K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
602.43K acquired · 578.52K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+578.52K
Price / share
—
Trade value
—
% of position
New position
8/10/2026
0.00→578.52K
Total
Net shares
+578.52K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/10/2026 | C · Conversion | +578.52K | — | — | New position | 0.00 | 578.52K |
| Total | +578.52K | $0.00 | ||||||
Derivative Transactions2
Director Stock Option (Right to Buy)
Direct
Converts to
Common Stock
23.90K shares
Shares
+23.90K
Strike price
16
Held after
23.90K
Exercisable
—
8/6/2026
Series B Preferred Stock
Indirect
Converts to
Common Stock
578.52K shares
Shares
−578.52K
Strike price
Held after
0.00
Exercisable
—
8/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) Direct | Common Stock23.90K shares | 8/6/2026 | A · Award | +23.90K | 16 | — | 23.90K |
| Series B Preferred Stock Indirect | Common Stock578.52K shares | 8/10/2026 | C · Conversion | −578.52K | — | 0.00 |